Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?
Alimentary Pharmacology & Therapeutics · 2023-04 · 57 (8) · 851-860
DOI: 10.1111/apt.17414 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2023-03. Verfasst von B W L C M Broeders und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Dyspepsia, Duodenal Diseases, Eosinophilia. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Abstract (Originalsprache)
Background
Functional dyspepsia (FD) is one of the most frequent conditions in gastroenterological outpatient health care. Most recent research in FD has shifted its focus to duodenal pathophysiological mechanisms, although current treatments still focus mainly the stomach.
Aim
The aim of the study was to provide a comprehensive overview of the pathophysiology of FD focusing on a paradigm shift from gastric towards duodenal mechanisms.
Methods
We conducted a literature search in PubMed for studies describing mechanisms that could possibly cause FD.
Results
The pathophysiology of FD remains incompletely understood. Recent studies show that duodenal factors such as acid, bile salt exposure and eosinophil and mast cell activation correlate with symptom pattern and burden and can be associated with gastric sensorimotor dysfunction. The evolving data identify the duodenum an interesting target for new therapeutic approaches. Furthermore, the current first‐line treatment, that is proton pump inhibitors, reduces duodenal low‐grade inflammation and FD symptoms.
Conclusion
Future research for the treatment of FD should focus on the inhibition of duodenal mast cell activation, eosinophilia and loss of mucosal integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
- Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
ORCID-Profile: B W L C M Broeders, K Raymenants, T Vanuytsel, J Tack
Zitieren
APA
Broeders, B. W. L. C. M., Carbone, F., Balsiger, L. M., Schol, J., Raymenants, K., Huang, I., Verheyden, A., Vanuytsel, T., & Tack, J. (2023). Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?. Alimentary Pharmacology & Therapeutics, 57(8), 851-860. https://doi.org/10.1111/apt.17414
Vancouver
Broeders BWLCM, Carbone F, Balsiger LM, Schol J, Raymenants K, Huang I, et al. Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?. Alimentary Pharmacology & Therapeutics. 2023;57(8):851-860. doi:10.1111/apt.17414
BibTeX
@article{Broeders2023,
author = {Broeders, B W L C M and Carbone, F and Balsiger, L M and Schol, J and Raymenants, K and Huang, I and Verheyden, A and Vanuytsel, T and Tack, J},
title = {Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {57},
number = {8},
pages = {851--860},
doi = {10.1111/apt.17414}
}
EUVIMED